Indication

Nummular Eczema

1 clinical trial

1 product

Clinical trial

An Investigator-initiated, Multi-center, Randomized, Double-blind, Placebo Controlled Study of Dupilumab to Demonstrate Efficacy in Subjects With Nummular Eczema

Status: Recruiting, Estimated PCD: 2026-01-31

Product